Prognostic significance of bone metastases and bisphosphonate therapy in patients with renal cell carcinoma

BACKGROUND: Bone metastases (BMs) are frequently present in patients with metastatic renal cell carcinoma (mRCC) and cause significant morbidity. OBJECTIVE: The purpose of this analysis was to assess the impact of BMs and bisphosphonate therapy (BT) on outcomes in mRCC. DESIGN, SETTINGS, AND PARTICI...

Full description

Saved in:
Bibliographic Details
Main Authors: McKay, Rana R., Lin, Xun, Perkins, Julia J., Heng, Daniel Y. C., Simantov, Ronit, Choueiri, Toni K.
Format: Artigo
Language:Inglês
Published: 2014
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4145043/
https://ncbi.nlm.nih.gov/pubmed/24613250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2014.02.040
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items